全文获取类型
收费全文 | 6334篇 |
免费 | 554篇 |
国内免费 | 1篇 |
专业分类
6889篇 |
出版年
2024年 | 7篇 |
2023年 | 56篇 |
2022年 | 148篇 |
2021年 | 245篇 |
2020年 | 129篇 |
2019年 | 127篇 |
2018年 | 147篇 |
2017年 | 137篇 |
2016年 | 226篇 |
2015年 | 342篇 |
2014年 | 388篇 |
2013年 | 461篇 |
2012年 | 578篇 |
2011年 | 612篇 |
2010年 | 322篇 |
2009年 | 288篇 |
2008年 | 334篇 |
2007年 | 351篇 |
2006年 | 330篇 |
2005年 | 280篇 |
2004年 | 243篇 |
2003年 | 248篇 |
2002年 | 246篇 |
2001年 | 44篇 |
2000年 | 36篇 |
1999年 | 56篇 |
1998年 | 50篇 |
1997年 | 41篇 |
1996年 | 34篇 |
1995年 | 32篇 |
1994年 | 25篇 |
1993年 | 18篇 |
1992年 | 21篇 |
1991年 | 15篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 9篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 12篇 |
1981年 | 10篇 |
1980年 | 13篇 |
1976年 | 10篇 |
1973年 | 7篇 |
1961年 | 6篇 |
1927年 | 7篇 |
1915年 | 6篇 |
1911年 | 6篇 |
1910年 | 6篇 |
1899年 | 7篇 |
排序方式: 共有6889条查询结果,搜索用时 15 毫秒
831.
832.
McNeela EA Burke A Neill DR Baxter C Fernandes VE Ferreira D Smeaton S El-Rachkidy R McLoughlin RM Mori A Moran B Fitzgerald KA Tschopp J Pétrilli V Andrew PW Kadioglu A Lavelle EC 《PLoS pathogens》2010,6(11):e1001191
Pneumolysin (PLY) is a key Streptococcus pneumoniae virulence factor and potential candidate for inclusion in pneumococcal subunit vaccines. Dendritic cells (DC) play a key role in the initiation and instruction of adaptive immunity, but the effects of PLY on DC have not been widely investigated. Endotoxin-free PLY enhanced costimulatory molecule expression on DC but did not induce cytokine secretion. These effects have functional significance as adoptive transfer of DC exposed to PLY and antigen resulted in stronger antigen-specific T cell proliferation than transfer of DC exposed to antigen alone. PLY synergized with TLR agonists to enhance secretion of the proinflammatory cytokines IL-12, IL-23, IL-6, IL-1β, IL-1α and TNF-α by DC and enhanced cytokines including IL-17A and IFN-γ by splenocytes. PLY-induced DC maturation and cytokine secretion by DC and splenocytes was TLR4-independent. Both IL-17A and IFN-γ are required for protective immunity to pneumococcal infection and intranasal infection of mice with PLY-deficient pneumococci induced significantly less IFN-γ and IL-17A in the lungs compared to infection with wild-type bacteria. IL-1β plays a key role in promoting IL-17A and was previously shown to mediate protection against pneumococcal infection. The enhancement of IL-1β secretion by whole live S. pneumoniae and by PLY in DC required NLRP3, identifying PLY as a novel NLRP3 inflammasome activator. Furthermore, NLRP3 was required for protective immunity against respiratory infection with S. pneumoniae. These results add significantly to our understanding of the interactions between PLY and the immune system. 相似文献
833.
Rachel Blundred Katie Myers Thomas Helleday Alastair S.H. Goldman Helen E. Bryant 《DNA Repair》2010,9(9):964-975
Accurate DNA replication is essential to genome integrity and is controlled by five human RecQ helicases, of which at least three prevent cancer and ageing. Here, we have studied the role of RECQL5, which is the least characterised of the five human RecQ helicases. We demonstrate that overexpressed RECQL5 promotes survival during thymidine-induced slowing of replication forks in human cells. The RECQL5 protein relocates specifically to stalled replication forks and suppresses thymidine-induced RPA foci, CHK1 signalling, homologous recombination and γH2AX activation. It is unlikely that RECQL5 promotes survival through translesion synthesis as PCNA ubiquitylation is also reduced. Interestingly, we also found that overexpressing RECQL5 relieves cells of the cell cycle arrest normally imposed by thymidine, but without causing mutations. In conclusion, we propose that RECQL5 stabilises the replication fork allowing replication to overcome the effects of thymidine and complete the cell cycle. 相似文献
834.
Background
Oligosaccharides containing a terminal Gal-α1,3-Gal moiety are collectively known as α-Gal epitopes. α-Gal epitopes are integral components of several medical treatments under development, including flu and HIV vaccines as well as cancer treatments. The difficulty associated with synthesizing the α-Gal epitope hinders the development and application of these treatments due to the limited availability and high cost of the α-Gal epitope. This work illustrates the development of a whole-cell biocatalyst for synthesizing the α-Gal epitope, Gal-α1,3-Lac. 相似文献835.
836.
837.
838.
839.